A Study to Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effect of Warfarin in Healthy Subjects
Clinical trial NCT02252731 · COMPLETED
Trial details
- NCT number
- NCT02252731
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2013-11-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.